New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

The Report

Verified funding, headquarters, and leadership news from the world's most innovative businesses

35 reports and counting

Updated daily with latest market intelligence
Fundraising
Breye Therapeutics

Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs

Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.

SalesTools Research
Sep 29, 2026
2 min read•€67.5M
Fundraising
Basecamp Research

Basecamp Research Raises $140M Series C for AI-Designed Medicines

Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.

SalesTools Research
Sep 23, 2026
2 min read•$140M
Fundraising
AusperBio

AusperBio Raises $120M Series C for Hepatitis B Oligonucleotide Therapies

AusperBio closed a $120 million Series C led by a strategic investor, with new investor RA Capital participating, to advance its hepatitis B candidate AHB-137.

SalesTools Research
Aug 27, 2026
2 min read•$120M
Headquarters
SpyGlass Pharma

SpyGlass Pharma Opens New Headquarters in Irvine

SpyGlass Pharma opened a 33,000-square-foot headquarters in Irvine, California, on August 27, 2026, moving from its former facility in Aliso Viejo as it prepares for its first product launch.

SalesTools Research
Aug 27, 2026
2 min read
Headquarters
Valvoline Global Operations

Valvoline Global Operations Selects Cincinnati for New Global Headquarters

Valvoline Global Operations said it will create a new global headquarters in Cincinnati, while its current location in Lexington, Kentucky becomes the central hub for the Americas region.

SalesTools Research
Aug 24, 2026
2 min read
Fundraising
Remepy

Remepy Raises $36M Series A to Advance Hybrid Drug Pipeline

Remepy raised a $36 million Series A led by O.G. Venture Partners and M Ventures to expand its Hybrid Drug pipeline and fund Phase III development of Hybridopa for Parkinson’s disease.

SalesTools Research
Aug 12, 2026
2 min read•$36M
Fundraising
Infinimmune

Infinimmune Raises $75M Series A for Human-Derived Antibody Drugs

Infinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance human-derived antibody programs in atopic dermatitis and inflammatory disease.

SalesTools Research
Aug 11, 2026
2 min read•$75M
Leadership
Nuwellis

Nuwellis Appoints Mike McCormick Chief Executive Officer

Nuwellis appointed former board director Mike McCormick as CEO, effective June 30, 2026, as John Erb transitions from his executive role and continues as Chairman.

SalesTools Research
Jun 16, 2026
2 min read
Fundraising
Pipe

Pipe Raises $50M in Series B

Pipe, a Aviation company based in Orlando, FL, has raised $50M in Series B at a $200M valuation led by UP.Partners, ArcTern Ventures, Breakthrough Energy Ventures.

Fundraising News Team
Jun 18, 2024
0 min read
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.